Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management

Eicosapentaenoic acid as a potential therapeutic approach to reduce cardiovascular risk in patients with end-stage renal disease on hemodialysis: A review

Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?

Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)

The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X-ray diffraction analysis

Metformin treatment decreases nitroxidative stress, restores nitric oxide bioavailability and endothelial function beyond glucose control

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

The Editor’s Round Table: Current Perspectives on Triglycerides and Atherosclerosis